Patents and Publications

Select a Category

Search

Synergistic Interactions for Improved Cancer Treatment

Inventors Barbara K. Felber, George N. Pavlakis, Sevasti KARALIOTA, Dimitrios STELLAS Assignees The United States Of America, As Represented By ...

ANTI-PD-L1 ANTIBODIES AND USES THEREOF

Inventors Horacio G. Nastri, Needham, MA Assignees Merck Patent GmbH, Darmstadt (DE) Abstract The present application relates to anti-PD-L1 antibodies ...

Rapid Profiling of the Glycosylation Effects on the Binding of SARS-CoV-2 Spike Protein to Angiotensin-Converting Enzyme 2 Using MALDI-MS with High Mass Detection

Authors Yuye Zhou, Congrui Tan, Renato Zenobi Organizations Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), ...

Co-opting the E3 Ligase KLHDC2 for Targeted Protein Degradation by Small Molecules

Authors Christopher M. Hickey, Katherine M. Digianantonio, Kurt Zimmermann, Alicia Harbin, Connor Quinn, Avani Patel, Peter Gareiss, Amanda Chapman, Bernadette ...

Epitope Mapping of Monoclonal Antibodies: A Comprehensive Comparison of Different Technologies

Authors Xibei Danga, Lars Guelenb, David Lutje Hulsikb, Grigori Ermakova, Edward J. Hsieha, Joost Kreijtzb, Judith Stammen-Vogelzangsb, Imke Lodewijksb, Astrid ...

Anti-BTN3A Antibodies For Use In Methods Of Treating Gastro-Intestinal Inflammatory Disorders

Inventors Sophie AGAUGUE, Paul Frohna Assignees Imcheck Therapeutics Abstract It is disclosed BTN3A inhibitory antibodies for use in treating ...

Transferrin Receptor (tfr)-selective Binding Peptides Capable of Crossing the Blood Brain Barrier and Methods of Use Thereof

Inventors Pawel Stocki, Krzysztof Bartlomiej Wicher, Jaroslaw Michal Szary, Julia Lynn Rutkowski Assignees Ossianix Inc Abstract The present invention relates ...

Prev
1
2
3
4
5
…
28
Next

text

Talk to Our Scientists

Our team is available to answer any of your questions about our products and services